Stock listing

Frankfurt:69C Tvardi Therapeutics, Inc. Aktie

German listing (Frankfurt) of Tvardi Therapeutics, Inc. · home listing NASDAQ:TVRD

Follow Tvardi Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · FWB:69C

€0.67 EUR 0.00 (0.0%)

Close on Oct 27, 2026

Day range
€0.63 – €0.67 EUROct 27, 2026
Market cap
€8.94M EURAt the close on Oct 27, 2026 · price × 13.34M shares outstanding
Tvardi Therapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:TVRD · Home$0.793 USD-0.070 (-8.1%)154,830$0.868$0.928$0.775$0.863Close on Oct 30, 2026
Frankfurt:69C€0.67 EUR0.00 (0.0%)—€0.63€0.67€0.63€0.67Close on Oct 27, 2026
Ticker
Frankfurt:69C
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Replays

  • Cara Therapeutics, Inc. (CARA) Q4 2023 Earnings Call

    Mon, Mar 04, 2024 · 4:30 PM ET

    Watch Transcript
  • Cara Therapeutics, Inc. (CARA) Q3 2023 Earnings Call

    Mon, Nov 13, 2023 · 4:30 PM ET

    Watch Transcript
  • Cara Therapeutics, Inc. (CARA) Q2 2023 Earnings Call

    Mon, Aug 07, 2023 · 4:30 PM ET

    Watch Transcript

Latest news

All Tvardi Therapeutics, Inc. news

Decks

Tvardi Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
15 in the last 12 months · 100 in all · newest Oct 14, 2026 · oldest 2021
Calls
14 calls with a replay · 14 with a transcript · latest Mar 4, 2024
Decks
11 decks · latest September 2026

Where Tvardi Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:TVRD · Home listingNASDAQUnited StatesUSD
Lang & Schwarz:A414VYLang & SchwarzGermanyEUR
LS Exchange:A414VYLS ExchangeGermanyEUR
Frankfurt:69C · This pageFrankfurtGermanyEUR
gettex:69CgettexGermanyEUR
Tradegate:69CTradegateGermanyEUR
Stuttgart:69C0StuttgartGermanyEUR
LSE:0HTCLSEUnited KingdomUSD
BOATS:TVRDBOATSUnited StatesUSD
BX Swiss:TVRDBX SwissSwitzerlandCHF
Munich:69CMunichGermanyEUR

Log in to ask 6ix AI your own questions about Tvardi Therapeutics, Inc.